# Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma

> **NCT06474182** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 32 (estimated)

## Conditions studied

- Multiple Myeloma
- Total Knee Replacement

## Interventions

- **PROCEDURE:** Blood sampling
- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT06474182
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-03
- **Final completion:** 2027-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06474182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06474182, "Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06474182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*